miRNA-145负向调控子宫内膜异位症中OCT4的表达

伍路; 赵庆华; 杨绍艳; 侯友芳; 张素仙

doi:10.12259/j.issn.2095-610X.S20211032

miRNA-145负向调控子宫内膜异位症中OCT4的表达

doi: 10.12259/j.issn.2095-610X.S20211032

昆明医科大学第二附属医院妇科，云南昆明　650101

基金项目: 云南省教育厅科学研究基金资助项目（2020J0183）；云南省科学技术厅-昆明医科大学联合专项基金资助项目（202001AY070001-227）；昆明医科大学第二附属医院院内基金资助项目（2018yk017）

详细信息

作者简介:
伍路（1988～），女，云南开远人，医学硕士，住院医师，主要从事妇科肿瘤及普通妇科工作

通讯作者:
张素仙，E-mail：zsx0902@126.com

中图分类号: R711.71
计量
- 文章访问数: 4271
- HTML全文浏览量: 2488
- PDF下载量: 9
- 被引次数: 0
出版历程
- 收稿日期: 2021-08-13
- 网络出版日期: 2021-10-29
- 刊出日期: 2021-10-30

MiRNA-145 Negatively Regulates OCT4 Expression in Endometriosis

Second Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650101，China

摘要

摘要: 目的探讨miRNA-145、OCT4在子宫内膜异位症（EMs）中的表达水平及临床意义。方法收集2018年8月至2020年8月昆明医科大学第二附属医院妇科收治的EMs患者30例（实验组）,不孕症（输卵管因素）患者30例（对照组），实验组术中取异位子宫内膜组织，对照组术中取在位子宫内膜组织，QPCR检测异位内膜组织、在位内膜组织中miRNA-145、OCT4的表达，Western印迹法检测组织中OCT4蛋白的表达。结果 EMs患者子宫内膜异位组织中较非EMs患者在位内膜组织中miRNA-145表达增高（P < 0.01），而OCT4表达下调（P < 0.01），2者呈现负相关关系。结论 miRNA-145有望成为子宫内膜异位症诊断的潜在标志物。miRNA-145与OCT4在子宫内膜异位症发生、发展中具有一定的作用，这一发现为EMs的发病机制及治疗提供了可能的研究方向及潜在靶点。
- 子宫内膜异位症 /
- miRNA-145 /
- OCT4 /
- 在位子宫内膜 /
- 异位子宫内膜
Abstract: Objective To study the expression and clinical significance of miRNA-145 and OCT4 in endometriosis. Methods From August 2018 to August 2020, 30 EMs patients （experimental group） and 30 patients with infertility caused by fallopian tube factors （control group） were collected. Ectopic endometrial tissues were collected during operation in experimental group and eutopic endometrial tissues in control group. The expressions of miRNA-145 and OCT4 in ectopic and eutopic endometrial tissues were detected by QPCR, and the expression of OCT4 protein in tissues was detected by Western blot. Results Compared with non-EMs patients, the expression of miRNA-145 in endometriotic tissues increased （P < 0.01）, while the expression of OCT4 decreased （P < 0.01）, showing a negative correlation between them. Conclusion miRNA-145 is expected to be a potential marker for diagnosis of endometriosis. miRNA-145 and OCT4 play a certain role in the occurrence and development of endometriosis, and this finding provides a possible research direction and potential target for the pathogenesis and treatment of EMS.
- Endometriosis /
- miRNA-145 /
- OCT4 /
- Eutopic endometrium /
- Ectopic endometrium

HTML全文

图 1 western blotting检测EU和EC中OCT4的表达水平

^***P < 0.001。

Figure 1. OCT4 expression in EC and EU tissues of patients with EMs was investigated using western blotting

下载: 全尺寸图片幻灯片

图 2 EMs患者异位内膜组织中miR-145与OCT4相关关系

Figure 2. Correlation between miR-145 and OCT4 in EMs patients

下载: 全尺寸图片幻灯片

表 1 QPCR扩增引物序列表

Table 1. Nucleotide sequences of the primers used for RT-PCR

引物名称	引物序列
miR-145-5p forward	5′ -GTC CACCGCAAATGCTTCTA-3′
miR-145-5P reverse	5′ -CCATCAGTCCCGTCTTGAAAC-3′
OCT4 forward	5′ -GTCCACCGC AAATGCTTCTA-3′
OCT4 reverse	5′ -CCATCAGTCCCGTCT TGAAAC-3
GAPDH forward	5′ -TTCCAGGAGCGAGATCCCT-3′
GAPDH reverse	5′ -CACCCATGACGAACATGGG-3′ ;
U6 forward	5′ -CTCGCTTCGGCAGCACAT-3′
U6 reverse	5′ -AACGCTTCACGAATTTGCGT-3′ .

下载: 导出CSV

表 2 2组患者中miR-145表达水平（$\bar x \pm s $）

Table 2. Expression level of miR-145 in two groups of patients （$\bar x \pm s $）

组别	n	miR-145	t	P
EC组	30	1.64 ± 0.74	3.459	0.001
EU组	30	1.00 ± 0.52	3.459	0.001

下载: 导出CSV

表 3 2组患者中OCT4表达水平（$\bar x \pm s $）

Table 3. Expression level of OCT4 in two groups of patients （$\bar x \pm s $）

组别	n	OCT4	t	P
EC组	30	0.68 ± 0.44	2.710	0.009
EU组	30	1.01 ± 0.52	2.710	0.009

下载: 导出CSV

参考文献(28)

[1]	Dimitrijevic D,Vasiljevic M,Anicic R,et al. Recurrence rate of ovarian endometrosis in patients treated with laparoscopic surgery and postoperative suppressive therapy[J]. Clin Exp Obstet Gynecol,2015,42(3):339-343.
[2]	Cucinella G,Granese R,Calagna G,et al. Oral contraceptives in the prevention of endometrioma recurrence:does the different progestins used make a difference[J]. Arch Gynecol Obstet,2013,288(4):821-827. doi: 10.1007/s00404-013-2841-9
[3]	Paka C,Miller J,Nezhat C. Predictive factors and treatment of recurrence of endometriosis[J]. Minerva Ginecol,2013,65(2):105-111.
[4]	Hirsch M, Davis C J. Preoperative assessment and diagnosis of endometriosis: Are we any closer [J] Curr Opin Obstet Gynecol, 2015, 27（4）: 284-290.
[5]	Chen T C,HsiehC H,Sarnow P. Supporting role for G' TPase rab 27 a in hepatitis C virus RNA repl ication through a novel miR-122-Mediated effect[J]. PLoS Pathog,2015,11(8):e1005116.
[6]	Marí-Alexandre J,Sánchez-Izquierdo D,Gilabert-Estellés J,et al. miRNAs regulation and its role as biomarkers in endometriosis[J]. Int J Mol Sci,2016,17(1):E93. doi: 10.3390/ijms17010093
[7]	Ohlsson Teague E M,Van der Hoek K H,Van der Hoek M B,et al. MicroRNA-regulated pathways associated with endometriosis[J]. Mol Endocrinol,2009,23(2):265-275. doi: 10.1210/me.2008-0387
[8]	Agrawal S,Tapmeier T,Rahmioglu N,et al. The miRNA Mirage:How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review[J]. Int J Mol Sci,2018,19(2):162-165.
[9]	姜丽,章蒙蒙,王思雪等. 基于生物信息学分析的子宫内膜异位症,iRNA-mRNA 调控网络的初步构建[J]. 中国现代医学杂志,2020,30(9):1-7. doi: 10.3969/j.issn.1005-8982.2020.09.001
[10]	Adammek M,Greve B,Kassens N,et al. MicroRNA miRNA - 145 in- hibits proliferation,invasiveness,and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and plu- ripotency factors[J]. Fertil Steril,2013,99(5):1346-1355. doi: 10.1016/j.fertnstert.2012.11.055
[11]	Wu Y,Liu S,Xin H,et al. Up-regulation of micro RNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells[J]. Cancer,2011,117(17):3989-3998.
[12]	Xu N,Papagiannakopoulos T,Pan G,et al. Micro-RNA-145regulates OCT4,SOX2,and KLF4and represses pluripotency inhuman embryonic stem cells[J]. Cell,2009,137(4):647-658. doi: 10.1016/j.cell.2009.02.038
[13]	Chang J H,Au H K,Lee W C,et al. Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis[J]. Fetil Steril,2013,99(5):1332-1339.
[14]	Coutinho L M,Ferreira M C,Rocha A L L,et al. New biomarkers in endometriosis[J]. Advances in Clinical Chemistry,2019,89(2):59-77.
[15]	Zhang H,Li G,Sheng X,et al. Upregulation of miR33b promotes endometriosis via inhibition of Wnt/betacatenin signaling and ZEB1 expression[J]. Molecular Medicine Reports,2019,19(3):2144-2152.
[16]	Li D,Jiang W,Jiang Y,et al. Preliminary functional inquiry of lncRNA ENST00000433673 in embryo implantation using bioinformatics analysis[J]. Systems Biology in Reproductive Medicine,2019,65(2):164-173.
[17]	郭斌,郭枫,郭永连等. miRNA. 145在前列腺癌中的表达及I临床意义[J]. 中国老年学杂志,2017,37(19):4824-4825. doi: 10.3969/j.issn.1005-9202.2017.19.060
[18]	Kim S I,Oh J S,Shin J Y,et al. Development of microRNA - 145 for therapeutie application in breast cancer[J]. J Control Release,2011,155(3):427-434.
[19]	Tang J,Li Z,Zhu Q,et al. miR-204-5p regulates cell prolifera- tion,invasion,and apoptosis by targeting IL-11 in esophageal squamous cell carcinoma[J]. J Cell Physiol,2020,235(3):3043-3055. doi: 10.1002/jcp.29209
[20]	沈燕燕,王青青. microRNA-21 在 2 型糖尿病伴冠心病患者中的表达及作用[J]. 心脑血管病防治,2021,21(2):194-196. doi: 10.3969/j.issn.1009-816x.2021.02.024
[21]	Chen M,Liu L X. MiR-525-5p repressed metastasis and anoikis resistance in cervical cancer via blocking UBE2C/ZEB1/2 signal axis[J]. Dig Dis Sci,2020,65(8):2442-2451. doi: 10.1007/s10620-019-05916-9
[22]	Li Y,Huo J,Pan X,et al. MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells[J]. Onco Targets Ther,2018,11(16):1275-1284. doi: 10.2147/OTT.S154517
[23]	Sun J,Cai X,Yung M M,et al. Mi R-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer[J]. Oncogene,2019,38(4):564-580. doi: 10.1038/s41388-018-0459-x
[24]	Mashayekhi P,Noruzinia M,Zeinali S,et al. Endometriotic mesenchymal stem cells epigenetic pathogenesis:Deregulation of miR-200b,miR-145,and let7b in a functionalimbalanced epigenetic disease[J]. Cell J,2019,21(2):179-185.
[25]	Kang K,Niu B,Wu C,et al. The construction and application of lentiviral overexpression vector of goat miR-204 in testis[J]. Res Vet Sci,2020,130(16):52-58.
[26]	Channakkar A S,Singh T,Pattnaik B,et al. MiRNA-137-mediated modulation of mitochondrial dynamics regulates human neural stem cell fate[J]. Stem Cells,2020,38(15):683-697.
[27]	Shariati F,Favaedi R,Ramazanali F,et al. Increased expression of stemness genes REX-1,OCT-4,NANOG,and SOX-2 in women with ovarian endometriosis versus normal endometrium:A case-control study[J]. Int J Reprod Biomed (Yazd),2018,16(12):783.
[28]	Jiang Z,Zhang C,Liu X,et al. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF-1α and Oct4[J]. Int J Oncol,2020,57(3):780-790. doi: 10.3892/ijo.2020.5097

相关文章(20)

[1]	崔培林, 宋玉霞, 王雪娟. 血清及组织miR-205预测卵巢型子宫内膜异位症术后复发价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241016
[2]	宋家美, 孟昱时, 陈静思, 陈琳, 范文, 闫瑾, 刘洋. 不同FET方案对子宫内膜结核患者内膜厚度、内膜血流及妊娠结局的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230911
[3]	张素仙, 冯莉嵋, 伍路, 杨绍艳, 赵庆华. miR-145通过调控人子宫内膜基质细胞OCT4的表达促进子宫内膜异位症的发展机制, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220220
[4]	陈紫红, 刘红, 刘明伟, 舒密, 南琼. MiRNA-145在消化系统恶性肿瘤中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210334
[5]	杨绍艳, 伍路, 张素仙. miRNAs在子宫内膜异位症发生发展中的作用研究进展, 昆明医科大学学报.
[6]	刘庆荣, 宋向菁, 王建兰, 万玉, 雷文涛, 李翠花. 宫腔镜对子宫内膜息肉因素不孕症的诊断, 昆明医科大学学报.
[7]	丁丽君, 田洁, 李晓兰. LAPTM4B在子宫内膜癌组织中表达及临床意义, 昆明医科大学学报.
[8]	任旭, 王沂峰, 戴丽冰. 子宫内膜异位症SCID小鼠动物模型的构建, 昆明医科大学学报.
[9]	曹欢欢, 黄淑娴, 刘琼花. 不同止血方法应用于卵巢子宫内膜异位囊肿腹腔镜剥离术中对卵巢功能的影响, 昆明医科大学学报.
[10]	杨琳琳. 高危子宫内膜癌术后辅助同步放化疗与单纯放疗的临床对比, 昆明医科大学学报.
[11]	赵霞. 腹腔镜与孕三烯酮联合对卵巢子宫内膜异位囊肿的疗效及预后, 昆明医科大学学报.
[12]	冯子豪. 腹腔镜手术联合地塞米松术腔冲洗治疗子宫内膜异位症的疗效观察, 昆明医科大学学报.
[13]	杨红梅. 血清β-HCG和子宫内膜厚度联合检测对早期异位妊娠的诊断价值, 昆明医科大学学报.
[14]	马菊香. 影响介入性超声治疗卵巢子宫内膜异位囊肿复发率的多因素分析, 昆明医科大学学报.
[15]	黄荣芳. 腹壁子宫内膜异位症53例临床分析, 昆明医科大学学报.
[16]	余韬. 腹腔镜手术联合内异消癥汤治疗子宫内膜异位症不孕疗效观察, 昆明医科大学学报.
[17]	陈茜. CYP1B1 432C/G基因多态性与子宫内膜异位症易感性的相关研究, 昆明医科大学学报.
[18]	冯亚妮. 子宫内膜异位症患者检测腹腔液及血清IL-4、IL-8价值分析, 昆明医科大学学报.
[19]	. 经阴道超声检查对子宫内膜病变初筛的临床诊断价值, 昆明医科大学学报.
[20]	. 子宫内膜间质肉瘤1例, 昆明医科大学学报.